BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32421339)

  • 1. Discovery of (1
    Wang C; Pei Y; Wang L; Li S; Jiang C; Tan X; Dong Y; Xiang Y; Ma Y; Liu G
    J Med Chem; 2020 Jun; 63(11):6066-6089. PubMed ID: 32421339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus.
    Berke JM; Dehertogh P; Vergauwen K; Van Damme E; Mostmans W; Vandyck K; Pauwels F
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.
    Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.
    Wu S; Zhao Q; Zhang P; Kulp J; Hu L; Hwang N; Zhang J; Block TM; Xu X; Du Y; Chang J; Guo JT
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
    Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation.
    Lu D; Liu F; Xing W; Tong X; Wang L; Wang Y; Zeng L; Feng C; Yang L; Zuo J; Hu Y
    ACS Infect Dis; 2017 Mar; 3(3):199-205. PubMed ID: 27989113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation.
    Mani N; Cole AG; Phelps JR; Ardzinski A; Cobarrubias KD; Cuconati A; Dorsey BD; Evangelista E; Fan K; Guo F; Guo H; Guo JT; Harasym TO; Kadhim S; Kultgen SG; Lee ACH; Li AHL; Long Q; Majeski SA; Mao R; McClintock KD; Reid SP; Rijnbrand R; Snead NM; Micolochick Steuer HM; Stever K; Tang S; Wang X; Zhao Q; Sofia MJ
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly.
    Toyama M; Sakakibara N; Takeda M; Okamoto M; Watashi K; Wakita T; Sugiyama M; Mizokami M; Ikeda M; Baba M
    Virus Res; 2019 Oct; 271():197677. PubMed ID: 31376401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of New Small Molecule Hits as Hepatitis B Virus Capsid Assembly Modulators: Structure and Pharmacophore-Based Approaches.
    Senaweera S; Du H; Zhang H; Kirby KA; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of novel sulfamoylbenzamide derivatives as HBV capsid assembly modulators.
    Wang S; Ren Y; Li Q; Wang Y; Jiang X; Xu S; Zhang X; Zhao S; Bradley DP; Woodson ME; Zhao F; Wu S; Li Y; Tian Y; Liu X; Tavis JE; Zhan P
    Bioorg Chem; 2022 Dec; 129():106192. PubMed ID: 36265355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379.
    Berke JM; Dehertogh P; Vergauwen K; Mostmans W; Vandyck K; Raboisson P; Pauwels F
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Evaluation of N-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV).
    Vandyck K; Rombouts G; Stoops B; Tahri A; Vos A; Verschueren W; Wu Y; Yang J; Hou F; Huang B; Vergauwen K; Dehertogh P; Berke JM; Raboisson P
    J Med Chem; 2018 Jul; 61(14):6247-6260. PubMed ID: 29906396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Based Discovery of
    Yang Y; Yan Y; Yin J; Hu J; Cai X; Hu J; Xia J; Wang K; Tang N; Huang L
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.
    Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV Agents.
    Kim W; Kang JA; Park M; Jeong PH; Kim YJ; Cho Y; Park SG; Kim YC
    J Med Chem; 2021 May; 64(9):5500-5518. PubMed ID: 33887912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors.
    Pan T; Ding Y; Wu L; Liang L; He X; Li Q; Bai C; Zhang H
    Eur J Med Chem; 2019 Mar; 166():480-501. PubMed ID: 30739828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
    Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors.
    Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X
    Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel dihydrobenzodioxine derivatives as HBV capsid protein inhibitors.
    Liu L; Wang M; Li C; Han X; Xie Y; Feng K; Zhang L; Chen Y; Jia H
    Bioorg Chem; 2022 Nov; 128():106052. PubMed ID: 35921789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel HBV capsid assembly modulators by structure-based virtual screening and bioassays.
    Wang Y; Wang Z; Liu J; Wang Y; Wu R; Sheng R; Hou T
    Bioorg Med Chem; 2021 Apr; 36():116096. PubMed ID: 33721800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.